Health
Trump Administration Begins Layoffs at CDC, FDA and Other Health Agencies
The Trump administration laid off thousands of federal health workers on Tuesday in a purge that included senior leaders and top scientists charged with regulating food and drugs, protecting Americans from disease and researching new treatments and cures.
Layoff notices began arriving at 5 a.m., workers said, affecting offices responsible for everything from global health to food safety. Senior officials based in the Washington area and Atlanta were reassigned to the Indian Health Service and asked to choose among locations including Alaska, Oklahoma and New Mexico — a tactic to force people out, employees said.
The layoffs and reassignments touch every aspect of the federal Department of Health and Human Services, and are part of what the administration has said is a vast restructuring of the agency. Entire units focused on reproductive health and preventing gun injuries were wiped out. So was a vaccine research program aimed at preventing the next pandemic.
On Tuesday afternoon, Senator Bill Cassidy, Republican of Louisiana and chairman of the Senate health committee, summoned Health Secretary Robert F. Kennedy Jr. to testify about the agency reorganization at a hearing on April 10.
Outside experts and former officials said the loss of expertise was immeasurable. Many described it as a “bloodletting.” Hundreds of people, many carrying handmade signs, gathered in the lobby of a National Cancer Institute building in the Maryland suburbs on Tuesday morning to witness the exodus of fired workers, but were dispersed so they could walk out without fanfare. Some employees, both current and former, were in tears.
But as staff members reeled and comforted one another, Mr. Kennedy posted a video on social media that showed him swearing in the new heads of the Food and Drug Administration, Dr. Martin A. Makary, and the National Institutes of Health, Dr. Jay Bhattacharya.
“Welcome aboard,” Mr. Kennedy said. “The revolution begins today.”
The cuts were intended to fulfill Mr. Kennedy’s plan, announced last week, to shrink his department from 82,000 to 62,000 employees. Tuesday’s layoffs affected 10,000 employees, on top of 10,000 who had already been fired or left voluntarily. The department did not respond to a request for comment on the record.
The restructuring is intended to bring communications and other functions directly under Mr. Kennedy, who has vowed to “make America healthy again.” It includes collapsing a number of agencies into a new division called the Administration for a Healthy America. Mr. Kennedy said last week that the department was “going to do more with less.”
Jessica C. Henry, 40, said she had been fired along with her entire team of communications and health education specialists at the National Institute of Dental and Craniofacial Research, a small branch of the National Institutes of Health with a budget of about $500 million. Their work focused on educating people about childhood dental health, including birth defects like cleft lips and palate, as well as water fluoridation and instructions on oral health maintenance as an aging adult.
Ms. Henry said she logged into her computer at her desk at N.I.H. headquarters in Maryland around 7 a.m., only to see an email notifying her of her termination.
“I also just feel so confused, and honestly kind of angry, because we hear a lot about how the administration wants to increase transparency,” she said in an emotional interview. “They want accountability to the American people for how their tax dollars are being spent. And from what I can tell, they just fired all of us who do that.”
Layoff notices began arriving at 5 a.m., workers said, affecting offices responsible for everything from global health to medical devices to communications at agencies including the F.D.A., the N.I.H. and the Centers for Disease Control and Prevention.
Mr. Kennedy is also eliminating entire but lesser known parts of his department, such as the Administration for Community Living, which supports programs that help older Americans and people with disabilities live independently. Advocates for disability rights say the cuts could deprive the most vulnerable Americans of housing, personal care and other services.
At the Substance Abuse and Mental Health Services Administration, cuts hollowed out entire offices including the internal policy lab, the team that administers a national survey of drug use, an office of behavioral health equity, the contracts management division and all 10 regional offices, according to Miriam Delphin-Rittmon, the former assistant health secretary for mental health and substance use. She left the agency on Jan. 20 and has been hearing from former colleagues.
The policy lab was established as part of the 21st Century Cures Act, a law passed by Congress in 2016.
“It’s not clear really the strategy,” Ms. Delphin-Rittmon said. “Those are important content areas.”
The cuts also fell on senior leaders, including the director of the center for mental health services, Dr. Anita Everett, who was hired into a senior position at the agency during the first Trump administration, and Michelle Greenhalgh, the agency’s director of legislative affairs, according to multiple people with direct knowledge of the filings.
“Today was simply a tragedy,” said Michael T. Osterholm, who directs the University of Minnesota’s Center for Infectious Disease Research and Policy, and has advised presidents of both parties. “There is so much intellectual capital that literally got swept under the rug today in this country, and we are going to pay a price for this for years to come.”
Dr. Bhattacharya, on his first day of work, sent an email to staff saying the layoffs would “have a profound impact on key N.I.H. administrative functions, including communications, legislative affairs, procurement and human resources.” He expressed his appreciation for the “scientists and staff whose work has contributed to lifesaving breakthroughs in biology and medicine.”
A number of top health officials received notice that they were being reassigned to regional offices of the Indian Health Service, which is responsible for providing federal health services to Native Americans and Alaska Natives.
At N.I.H., several institute directors — including Dr. Jeanne Marrazzo, head of the National Institute of Allergy and Infectious Diseases, the institute formerly led by Dr. Anthony S. Fauci — were reassigned. So were Dr. Fauci’s wife, Christine Grady, the head of the N.I.H. Office of Bioethics, and Dr. Clifford Lane, a close ally of Dr. Fauci’s who oversaw clinical research.
At the F.D.A., the top tobacco regulator, Brian King, was reassigned. At the C.D.C., several leaders, including Kayla Laserson, who ran the global health center, also were reassigned to the Indian Health Service.
The health service is chronically understaffed and underfunded; the reassignment notices said it has an “untenable vacancy rate” of 30 percent. Mr. Kennedy recently lamented that it has been “treated as the redheaded stepchild at H.H.S.” and said President Trump wants him to “rectify this sad history.”
Those who received the reassignments were given until Wednesday to decide whether to accept the offer, or leave their jobs.
Some workers knew that they would be affected by the layoffs. At the department headquarters in Washington, officials responsible for minority health and infectious disease prevention were told Friday that their offices were being eliminated, according to employees.
Others were caught off guard. At the F.D.A., senior leaders were pushed out and offices focused on food, drug and medical device policy were hit with deep staff reductions amounting to about 3,500 agency staff members. On Friday, the agency’s top vaccine regulator, Dr. Peter Marks, was forced to resign under pressure. He lashed out at Mr. Kennedy afterward, saying the secretary “doesn’t care about the truth.”
Some F.D.A. workers said that they discovered they had been fired when they attempted to scan their badges to get into the building early Tuesday. The office of the center director for veterinary medicine was wiped out, according to a person familiar with the cuts. That included veterinarians leading bird flu response for the agency.
Employees of several F.D.A. labs around the United States were also let go, including those who test medical products in Detroit and San Juan, Puerto Rico, and those who test food in San Francisco and Chicago.
“The F.D.A. as we’ve known it is finished, with most of the leaders with institutional knowledge and a deep understanding of product development and safety no longer employed,” Dr. Robert Califf, who ran the Food and Drug Administration during the Biden administration, wrote on social media. He said “history will see this” as “a huge mistake.”
At the C.D.C., which Mr. Kennedy wants to pare back to focus only on infectious disease, the reorganization is likely to have immediate effects. Offices devoted to the study of other programs, including reproductive health, chronic disease and gun violence prevention, were disbanded.
The administration has eliminated offices dedicated to protecting workers in various industries, including those that inspect mines for safety. A two-year project to study the effects of radiation was eliminated, as was an ongoing project on lead contamination in Milwaukee.
“These cuts to agency experts and programs leave our country less safe, less prepared and without the necessary talent and resources to respond to health threats,” Dr. Mandy Cohen, who led the Centers for Disease Control and Prevention during the Biden administration, said in a text message.
Some infectious disease teams were also laid off. A group focused on improving access to vaccines among underserved communities was cut, as was a group of global health researchers who were working on preventing transmission of H.I.V. from mother to child.
H.I.V. prevention was a big target overall. The Trump administration had been weighing moving the C.D.C.’s division of H.I.V. prevention to a different agency within the health department. But on Tuesday, teams leading H.I.V. surveillance and research within that division were laid off. It was unclear whether some of those functions would be recreated elsewhere.
Employees laid off at the agency included those studying injuries, asthma, lead poisoning, smoking and radiation damage, as well as those that assess the health effects of extreme heat and wildfires.
Communications offices were hit particularly hard across agencies including the N.I.H., C.D.C. and F.D.A. Renate Myles, the communications director at the National Institutes of Health, received a notice of reassignment. At the C.D.C., specialists in tuberculosis communications and education were laid off.
Mr. Kennedy, who promised “radical transparency,” has said he wants to consolidate communications under his purview.
The H.H.S. “is centralizing communications across the department to ensure a more coordinated and effective response to public health challenges, ultimately benefiting the American taxpayer,” Emily Hilliard, deputy press secretary for the department, said in an email on Friday.
But other divisions responsible for providing the public with information were hit, too.
The team that responds to Freedom of Information Act requests at the C.D.C. was eliminated, and a similar team at the F.D.A. was deeply cut, according to sources familiar with each office. They spoke on condition of anonymity out of fear of reprisal.
Processing such requests is required by law, but can be a painstaking process, given rules requiring the redaction of information such as a company’s trade secrets.
Benjamin Mueller, Gina Kolata, Aishvarya Kavi and Margot Sanger-Katz contributed reporting.
Health
Cases of ‘white plague’ rising in US as doctors warn of ‘rebound effect’
NEWYou can now listen to Fox News articles!
A potentially deadly disease known as “the white plague” has been rising in the U.S. since the pandemic, health officials have warned.
Tuberculosis (TB) gets its nickname from the pale appearance of those affected with the disease.
After a dip in 2020 with the onset of COVID – likely due to underdiagnosis and reduced screenings, according to health experts – cases of TB have increased every year since.
MENINGITIS CASES RISE IN MAJOR MIDWESTERN CITY, PROMPTING PUBLIC HEALTH ALERT
More than 10,600 cases were confirmed in 2024, which is around three people for every 100,000, per the latest available data from the Centers for Disease Control and Prevention.
This marks the third consecutive annual increase, and the total 2024 case count is the highest annual number since 2013.
After a dip in 2020 with the onset of COVID, cases of tuberculosis have increased every year since. (iStock)
Despite the recent increase, TB rates in the U.S. remain relatively low compared to many parts of the world, as the global average is about 131 cases per 100,000, per the World Health Organization. That’s approximately 40 times higher globally compared to the U.S.
TB is a curable bacterial infection that targets the lungs, but can also infect other organs, according to Johns Hopkins. It is spread through airborne particles released when an infected person coughs, speaks or sneezes.
URGENT WARNING ISSUED BY CDC AS CHIKUNGUNYA VIRUS OUTBREAK HITS VACATION DESTINATION
Renuga Vivekanandan, M.D., professor at Creighton University School of Medicine and VP and CMO of CHI Health Physician Enterprise Midwest, said the rise in tuberculosis cases in the U.S. is concerning, but noted that it was foreseeable.
“The COVID-19 pandemic effectively disrupted TB surveillance and treatment programs across the country,” the doctor, who is board-certified in internal medicine and infectious diseases, told Fox News Digital.
TB is a curable bacterial infection that targets the lungs, but can also infect other organs, according to Johns Hopkins. (Getty)
“What we’re seeing now is largely a rebound effect – latent TB infections that went undetected or untreated during the pandemic are now activating.”
Another factor is a return to international travel and increased migration from countries where TB is more prevalent, according to Vivekanandan.
The uptick has also strained healthcare systems. “Local and state public health TB programs became understaffed during the pandemic, and that capacity hasn’t fully recovered,” the doctor said.
Symptoms of disease
While around 25% of people have likely been infected with the TB bacteria, about 5% to 10% will go on to develop active disease, according to health agencies.
MEASLES OUTBREAK POSES RISK OF ‘IRREVERSIBLE’ BRAIN DAMAGE, HEALTH OFFICIALS WARN
A person with a latent infection has been infected with the tuberculosis bacteria, but the bacteria are inactive in the body. While latent-stage TB is not contagious, it can develop into active disease in 5% to 10% of people.
Only people with active TB disease in the lungs or throat can spread the infection.
While around 25% of people have likely been infected with the TB bacteria, about 5% to 10% will go on to develop active disease. (iStock)
Those who get sick with TB may experience mild symptoms, including coughing, chest pain, fatigue, weight loss, weakness, fever and night sweats, per the CDC. In some cases, however, the disease can also affect the kidneys, spine, skin and brain.
CLICK HERE FOR MORE HEALTH STORIES
“TB can affect any organ of the body, but it causes disease in the lung in over 80% of cases,” Masae Kawamura, M.D., a former TB control director in San Francisco and a tuberculosis clinician, previously told Fox News Digital. “This is dangerous because it causes cough, the mechanism of airborne spread.”
“TB can affect any organ of the body, but it causes disease in the lung in over 80% of cases.”
In more severe cases, patients may cough up blood, noted Kawamura, who serves on the board of directors of Vital Strategies, a global public health organization.
“Often, there are minimal symptoms for a long time, and people mistake their occasional cough with allergies, smoking or a cold they can’t shake off,” she added.
Risk factors, treatment and prevention
“The good news is that TB is both preventable and treatable,” Vivekanandan said.
“People who are at higher risk – including those born in or traveling frequently to high TB-burden countries, individuals living in crowded conditions, or those who are immunocompromised – should speak with their doctor about TB testing.”
“People who are at higher risk – including those born in or traveling frequently to high TB-burden countries, individuals living in crowded conditions, or those who are immunocompromised – should speak with their doctor about TB testing,” one doctor noted. (iStock)
Other high-risk groups include people who have diabetes, are malnourished, use tobacco and/or drink excess amounts of alcohol. Babies and children are also more vulnerable to the disease.
Doctors typically use a skin or blood test to detect TB infection, followed by imaging or sputum (mucus) testing to confirm active disease, per the CDC.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
The disease is treated with antibiotics that are taken every day for four to six months, the CDC states. Some of the most common include isoniazid, rifampicin, pyrazinamide and ethambutol.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
Failure to take the complete course of medications can cause the bacteria to become drug-resistant, which means it does not respond to standard antibiotics. Drug-resistant TB is more difficult and costly to treat and requires longer, more complex medication regimens, according to experts.
If TB goes untreated, it is fatal in about half of its victims.
“Latent TB, which causes no symptoms and is not contagious, can be treated and cured before it ever progresses to active TB, which is infectious,” the doctor pointed out. (iStock)
“Latent TB, which causes no symptoms and is not contagious, can be treated and cured before it ever progresses to active TB, which is infectious,” Vivekanandan said.
“Identifying and treating latent infection is one of the most powerful tools we have for protecting both individual patients and the broader community.”
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
The U.S. Preventive Services Task Force recommends screening only for populations at increased risk rather than for the general population.
Health
Hormone therapy boosts weight loss drug results by 35% in women, study finds
NEWYou can now listen to Fox News articles!
For women struggling with weight gain after menopause, a new study suggests that adding hormone therapy to a popular obesity drug may lead to greater weight loss.
Postmenopausal women lost about 35% more weight when using menopausal hormone therapy alongside tirzepatide — a GLP-1-based, Food and Drug Administration-approved drug for the overweight and obese — compared to those taking the drug alone, according to a Mayo Clinic study.
The findings, published in February in The Lancet Obstetrics, Gynaecology, & Women’s Health, highlight a possible new strategy for addressing weight gain after menopause, when hormonal shifts can increase the risk of obesity, cardiovascular disease and Type 2 diabetes.
STOPPING OZEMPIC? NEW STUDY REVEALS SURPRISING WEIGHT REGAIN RESULTS AFTER GLP-1S
“This study provides important insights for developing more effective and personalized strategies for managing cardiometabolic risk in postmenopausal women,” Dr. Regina Castaneda, the study’s first author, said in a statement.
A new study found that postmenopausal women lost more weight when combining hormone therapy with a GLP-1-based drug. (iStock)
Researchers analyzed 120 postmenopausal women who were overweight or obese who took tirzepatide for at least 12 months, including 40 who also used hormone therapy and 80 who did not.
Hormone therapy is commonly used to treat menopause symptoms like hot flashes and night sweats, while tirzepatide helps regulate appetite and blood sugar.
WEIGHT LOSS MEDICATIONS COULD IMPACT SEXUAL HEALTH IN UNEXPECTED WAYS
Women in the hormone therapy group lost an average of 19.2% of their body weight, compared to 14.0% in the non-hormone group — about 35% greater relative weight loss — with more women reaching significant weight-loss thresholds, according to the study.
Despite the results, researchers emphasized that the study was observational and cannot prove cause and effect.
Hormonal changes after menopause can increase weight gain and health risks. (iStock)
“Because this was not a randomized trial, we cannot say hormone therapy caused additional weight loss,” said Dr. Maria Daniela Hurtado Andrade, an endocrinologist at Mayo Clinic and senior author of the study.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
Outside experts agree that the findings must be interpreted cautiously.
“As with all observational studies, we need to interpret this study with a grain of salt,” Dr. Gillian Goddard, a board-certified endocrinologist, told Fox News Digital.
Goddard, who is also an adjunct assistant professor of medicine at the NYU Grossman School of Medicine, noted that the findings show a link but do not prove that hormone therapy, which usually includes estrogen, directly caused the additional weight loss.
CLICK HERE FOR MORE HEALTH STORIES
“There may be important differences between the two groups,” she added. “For one thing, the group taking estrogen may be healthier than the groups that didn’t take estrogen. … Healthier people are more likely to eat a healthy diet and exercise in addition to taking tirzepatide. That could lead to more weight loss.”
Tirzepatide, a GLP-1-based drug, may be more effective for weight loss when paired with hormone therapy, according to researchers. (iStock)
Symptom relief from the therapy may have also improved sleep and well-being, making it easier for the group to maintain diet and exercise routines, Hurtado Andrade noted.
Researchers also pointed to a possible biological explanation. Preclinical data suggest estrogen may enhance the appetite-suppressing effects of GLP-1-based medications like tirzepatide, according to the study.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
Goddard said that theory is plausible but unproven.
Hormone therapy may ease menopause symptoms and help women stay on track with diet and exercise. (iStock)
“The other possibility is that estrogen interacts with tirzepatide in some way that makes it more potent,” she said. “We will need randomized studies to get a better handle on that.”
As for safety, experts say using the two together appears safe for most women. However, hormone therapy is not recommended for all patients, especially those with a history of certain cancers, blood clots or other underlying health risks, according to the Mayo Clinic.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
Researchers say future randomized trials will aim to confirm the findings and explore whether the combination also improves broader cardiometabolic health outcomes, according to the study.
Experts say more research is needed to confirm whether hormone therapy directly boosts weight loss results with GLP-1 drugs. (iStock)
“If confirmed, this work could speed the development and adoption of new, evidence-based strategies to reduce this risk for millions of postmenopausal women navigating this life stage,” Hurtado Andrade said.
Fox News Digital has reached out to the study authors for comment.
Health
The Best Belly Fat-Burning Foods That Shrink Your Waist up to 3X Faster
Use left and right arrow keys to navigate between menu items.
Use escape to exit the menu.
Sign Up
Create a free account to access exclusive content, play games, solve puzzles, test your pop-culture knowledge and receive special offers.
Already have an account? Login
-
Sports1 week agoIOC addresses execution of 19-year-old Iranian wrestler Saleh Mohammadi
-
New Mexico1 week agoClovis shooting leaves one dead, four injured
-
Miami, FL4 days agoJannik Sinner’s Girlfriend Laila Hasanovic Stuns in Ab-Revealing Post Amid Miami Open
-
Tennessee6 days agoTennessee Police Investigating Alleged Assault Involving ‘Reacher’ Star Alan Ritchson
-
Minneapolis, MN4 days agoBoy who shielded classmate during school shooting receives Medal of Honor
-
Politics1 week agoSchumer gambit fails as DHS shutdown hits 36 days and airport lines grow
-
Science1 week agoRecord Heat Meets a Major Snow Drought Across the West
-
Technology1 week agoYouTube job scam text: How to spot it fast